Why I'm kicking myself over Pro Medicus Ltd shares

Pro Medicus Ltd (ASX: PME) announced a new $14 million contract today.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Pro Medicus Ltd (ASX: PME) share price soared 6% to $19 this morning after the software-as-service medical imaging business announced it has signed a new 7-year contract worth $14 million with leading U.S. healthcare and private hospital group Duke Health.

The stock is now up an incredible 24x over just the past 5 years from 79 cents per share to $19 to leave me kicking myself for not buying into this growth story earlier, despite it ticking all the boxes as a small-cap business to own.

Compounding my imbecilic approach to this golden investment opportunity was my failure to take a material position when I did first buy in around $7.70 per share.

Even though I've now comfortably doubled my money in no time, I'm still stewing at my decision making on Pro Medicus.

After all excluding yourself from a huge share market winner is a more expensive mistake than buying a company that goes bankrupt.

For example if you miss out on a business that produces a 300% return because you believe "it's too expensive" or "you've missed the boat" then you're actually costing yourself more money than writing off 100% of an investment.

As I've written before if you write off a business as 'too expensive' you may effectively exclude yourself permanently from the best growth businesses in global share markets.

For example stocks like Amazon and Salesforce Inc. in the U.S. have produced eye-watering returns, but have always looked very expensive on conventional valuation metrics.

Pro Medicus appears attractive as an investment as it's founder led, profitable, and has a market-leading product (Visage 7) in a healthcare space flush with cash for any successful small-cap business.

As a cloud-based software business it also boasts attractive economics such as high gross profit margins, scalability, and huge global addressable markets via the reach of the internet.

As such it could be a mistake to dismiss Pro Medicus on valuation grounds given markets are forward looking and it keeps winning major healthcare contracts with cutting-edge healthcare groups in the U.S.

Therefore I'd suggest anyone keen on the Pro Medicus story looks to 'dollar cost average' into the business in order to spread the risk of overpaying.

I will wait a little to buy more shares as I expect I will be offered a cheaper price before the company's full year profit report in August.

I'd also caution that it remains a high-risk investment on valuation grounds and suitable only for those with a stomach for volatility.

Tom Richardson owns shares of Pro Medicus Ltd and Amazon.  You can find Tom on Twitter @tommyr345 The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends Pro Medicus Ltd. The Motley Fool Australia has recommended Pro Medicus Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

These were the best-performing ASX 200 shares in March

These shares made their shareholders smile in March thanks to some very big gains.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

3 ASX All Ords shares up 50%+ in March

These ASX shares have been on fire this month. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

These shares are having a good session on hump day. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Consumer Staples & Discretionary Shares

If you'd put $20,000 in this ASX retail stock at the start of 2023, you'd have $134,000 now

This online retailer has executed a remarkable turnaround for its investors.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX shares this Tuesday.

Read more »